My spirits have been lifted a bit in the last week… not so much by the general state of the world (unemployment is horrifying, the pandemic remains scary, politics has sunk even further into the gutter, a big chunk of the world is literally on fire, again), but by the return of some seasonal patterns […]
Articles
I shared part one of our Friday File with you this morning, when I took some time to dig into a nanocap idea being teased by Keith Schaefer, so part two will be a little more brief… just a few quick notes about things of interest this week, and some minor moves in the Real […]
The plan for today? Figure out what other name might be associated with Nikola Tesla, and use it as the name for a new-age company. Venture funding should flow without regard to merit, and you might just be able to go straight to an IPO and buy that private island. Nikola (NKLA) is taken, thanks […]
It’s “goodwill toward all” season, right? So now is the time to get ready to be nice to yourself. I don’t know whether this trade war will end, or if impeachment will lead to something bigger, or whether President Trump will find a way to goose the stock market again next year to boost his […]
This week brought yet another push-pull to the markets as investors attempt to figure out whether Lucy is going to pull the football away from Charlie Brown again in the China trade talks, but the narrative that struck me as most interesting on the week was the line that was drawn in the economy by […]
So… anything happen this week? 🙂 We’ll start with a few headline-grabbers from the Real Money Portfolio in the technology world, slide into a little teaser solution for you, and then share some updates on a couple small buys I made, plus some additions to the watchlist, along with the usual blather… Xilinx (XLNX) had […]
As we close in on the end of the first quarter, it’s time to release some more data — I just posted the 2019 teaser tracking spreadsheet for you, you can find it on the tracking page along with all our previous years and use it both to see what we’ve been covering so far […]
Today we’ve got a quickie for you, in response to a couple questions about the Cabot Top Ten Trader teaser pitch that came out over the weekend. Top Ten Trader ($137/year) is a short-term newsletter edited by Mike Cintolo, he basically sifts out ten of their favorite growth stocks each week, and I think they’re […]
I haven’t written about closed-end funds in a while, so when I was skimming through the possible teaser pitches I might cover today this one caught my eye. It’s for Sovereign Man’s 4th Pillar newsletter, helmed by Tim Staermose (it’s pricey at $1,995/year but does, at least, offer a 30-day money-back refund, something most of […]
If you’re wondering whether it’s interest rates or just “worry about overvaluation or growth” that’s making the stock market go crazy this week, or whether it’s the trade war or political upheaval or something else, well, join the club. There’s some indication that traders are in fear of the “slowdown” that could be caused by […]
I like David Einhorn, though I don’t know him (at least as far as I know, he was a year or two ahead of me in school, at the same University and in the same major, so perhaps we shared a beer or a study session at some point), but someone has to remind him […]
Nicholas Vardy has a newer low-end advisory called Smart Money Masters, and it looks like he’s aiming to be one of the “whale watchers” who run 13F-following services — the folks who watch the big buys by Warren Buffett and a couple dozen of the big hedge funds and institutional investors, and try to emulate […]
Today’s teaser happens to also concern a stock that I’ve been curious about, so I’m taking the opportunity to follow the hints down the rabbit hole and do a little chewing on whatever it is I find down there. The teaser ad comes in from Motley Fool Canada in an ad for their Stock Advisor […]
I’ve got a few thoughts for you on some companies I follow and own, and a little follow-up on last week’s chatter about hedge funds, but first I thought you’d like a quick teaser solution for your Friday File fun… The pitch is for Stephen Petranek’s Breakthrough Technology Alert — there’s been some discussion recently […]
Most of us are self-directed investors, for good or ill — you’re probably here because you like researching or trading stocks, and I obviously feel the same. But should we be trusting ourselves to manage our money? I know that sounds like a fatuous question — obviously, we should trust ourselves much more than we […]
There’s a good, blustery ad up from Brian Hicks and the folks at Angel Publishing about Warren Buffett and his insider connections … … connections that have not only helped him make big, profitable deals for his shareholders (including yours truly, so thanks for that), but that have enabled him to drive government policy to […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Stansberry research Tim Phaeln at investors alley Contrarian outlook...
I have been disappointed in Fitzg's newsletter. But I have picked up good advice from Tim Plaehn's Investors' Alley. He...
From Bret Jensen of Investors Alley: Amicus Therapeutics (NASDAQ: FOLD), another attractive small biotech concern se...
Well, thats a switch. Ordinarily I'd say I've gotten some of the worst advice from Investors Alley in the last year....
I still subscribe to The Oxford Income Letter. It's still okay and I do like reading their take on the markets. I am al...
Change of subject, I received an email from Investor's Alley saying that 19 major banks to shut down. Do you have any c...
(Do your own Due Diligence: No position in either company - KennyG) 2 Attractive Small-Cap Biotech Stocks On The Verge ...
Hi Rae: I happened to be awake because the any-minute coming of Santa Claus excites me. $EW is a classy company whose...
$EW Dr. KSS what is your opinion of $EW - Edwards Lifesciences. It quietly goes about its business with very little p...